Evan Seigerman – BMO Capital

BMO Capital

A BMO Capital analyst with 41 tracked ratings across 30 distinct tickers has a 4.3 out of 5 stars track record and a 51% success rate on the captured sample, covering a diverse range of sectors.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

21 days ago

2026-05-14 00:00:00+00

Track record

Aggregated

No track record data

Bullish: 17
Hold: 3
Bearish: 1

Aggregated

51% success rate

Bullish: 0
Hold: 1
Bearish: 0

Aggregated

Not available

Bullish: 6
Hold: 2
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
BIIB	2026-05-14	hold	$196.00	Aggregated
BMY	2026-05-13	hold	$60.00	Aggregated
ABCL	2026-05-11	buy	$7.00	Aggregated
NBIX	2026-05-11	hold	$144.00	Aggregated
IRON	2026-05-05	buy	$100.00	Aggregated
ABBV	2026-05-04	buy	$258.00	Aggregated
AMGN	2026-05-04	buy	$400.00	Aggregated
MRK	2026-05-04	buy	$135.00	Aggregated
VRTX	2026-05-04	buy	$600.00	Aggregated
REPL	2026-04-13	sell	$1.00	Aggregated
GILD	2026-04-07	buy	$174.00	Aggregated
SRRK	2026-03-18	buy	$70.00	Aggregated
TSHA	2026-03-18	buy	$8.00	Aggregated
GPCR	2026-03-16	buy	$145.00	Aggregated
NBIX	2026-02-12	hold	$140.00	Aggregated
BIIB	2026-02-09	hold	$196.00	Aggregated
TERN	2025-12-09	buy	$54.00	Aggregated
LLY	2025-12-04	buy	$1200.00	Aggregated
TERN	2025-11-18	buy	$30.00	Aggregated
TERNTERNS PHARMACEUTICALS INC	2025-11-18	unknown	$30.00	Aggregated
LLYLILLY(ELI) & CO	2025-11-06	unknown	$1100.00	Aggregated
TERN	2025-11-04	buy	$22.00	Aggregated
PTGX	2025-10-13	buy	$112.00	Aggregated
VRTXVERTEX PHARMACEUTICALS, INC.	2025-08-05	unknown	$530.00	Aggregated
INCYINCYTE CORP.	2025-07-30	unknown	$60.00	Aggregated
IRON	2025-05-12	buy	$120.00	Aggregated
IRONDISC MEDICINE INC	2025-05-12	unknown	$120.00	Aggregated
NBIXNEUROCRINE BIOSCIENCES, INC.	2025-05-06	unknown	$115.00	Aggregated
GILDGILEAD SCIENCES, INC.	2025-04-17	unknown	$120.00	Aggregated
BIIBBIOGEN INC	2025-02-13	hold	$139.00	Aggregated
BMYBRISTOL-MYERS SQUIBB CO.	2024-11-12	unknown	$61.00	Aggregated
NUVBNUVATION BIO INC - ORDINARY SHARES - CLASS A	2022-08-02	unknown	$2.50	Aggregated
AMGNAMGEN INC.	2022-04-28	unknown	$243.00	Aggregated
CADL	2022-03-31	buy	$12.00	Aggregated
CADLCANDEL THERAPEUTICS INC	2022-03-31	unknown	$12.00	Aggregated

Tickers covered(30)

Ticker	Ratings	Last rating	Sources
BIIB	2	2026-05-14	Aggregated
BMY	1	2026-05-13	Aggregated
ABCL	1	2026-05-11	Aggregated
NBIX	2	2026-05-11	Aggregated
IRON	2	2026-05-05	Aggregated
ABBV	2	2026-05-04	Aggregated
AMGN	2	2026-05-04	Aggregated
MRK	2	2026-05-04	Aggregated
VRTX	1	2026-05-04	Aggregated
REPL	1	2026-04-13	Aggregated
GILD	2	2026-04-07	Aggregated
SRRK	1	2026-03-18	Aggregated
TSHA	1	2026-03-18	Aggregated
GPCR	2	2026-03-16	Aggregated
TERN	3	2025-12-09	Aggregated
LLY	1	2025-12-04	Aggregated
TERNTERNS PHARMACEUTICALS INC	1	2025-11-18	Aggregated
LLYLILLY(ELI) & CO	1	2025-11-06	Aggregated
PTGX	2	2025-10-13	Aggregated
VRTXVERTEX PHARMACEUTICALS, INC.	1	2025-08-05	Aggregated
INCYINCYTE CORP.	1	2025-07-30	Aggregated
IRONDISC MEDICINE INC	1	2025-05-12	Aggregated
NBIXNEUROCRINE BIOSCIENCES, INC.	1	2025-05-06	Aggregated
GILDGILEAD SCIENCES, INC.	1	2025-04-17	Aggregated
BIIBBIOGEN INC	1	2025-02-13	Aggregated
BMYBRISTOL-MYERS SQUIBB CO.	1	2024-11-12	Aggregated
NUVBNUVATION BIO INC - ORDINARY SHARES - CLASS A	1	2022-08-02	Aggregated
AMGNAMGEN INC.	1	2022-04-28	Aggregated
CADL	1	2022-03-31	Aggregated
CADLCANDEL THERAPEUTICS INC	1	2022-03-31	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.